A novel strategy that could potentially form a primary component of a universal influenza vaccine capable of providing long-lasting protection was suggested by researchers. Current vaccines against the influenza virus elicit an antibody response specific for proteins on the outside of the virus, specifically the hemagglutinin (HA) protein. Yearly vaccines are made by growing the flu virus in eggs. The viral envelope proteins, including HA, are cleaved ...
View the Original article
